Antiplatelet agents: Glycoprotein IIb/IIIa inhibitors
These drugs may increase the risk of intra- and postprocedural bleeding in patients who undergo various minimally-invasive biopsy procedures (See under 'hemoptysis' and PMID 23617483)
These drugs may increase the risk of intra- and postprocedural bleeding in patients who undergo various minimally-invasive biopsy procedures (See under 'hemoptysis' and PMID 23617483)